15 Oct, 2024 DLA Piper Genomics Series: From crisp packets to CRISPR, and beyond By Rebecca Lawrence Genome editing is an immensely powerful tool which has the potential to revolutionise the life sciences, including medicine and...
14 Aug, 2024 Drug discovery and development in the age of AI By Rebecca Lawrence DLA Piper’s inaugural Life Sciences Index is a survey and study series about perceptions of innovation and growth in the life sciences...
28 Jun, 2024 The evolving landscape of patent term extensions By Rebecca Lawrence Petros Nafpliotis Part 1: Supplementary Protection Certificates – harmonisation Following the European elections earlier this month, innovator’s eyes are...
05 Feb, 2024 A patent perspective on the battle against cancer By Rebecca Lawrence 4 February is World Cancer Day, an international day marked to raise awareness of cancer and to encourage its prevention, detection, and...
13 Dec, 2023 Experimental evidence in patent litigation – Rules for fair play By Rebecca Lawrence The technical nature of patent litigation means that experiments are often an essential (and sometimes the only) way to prove key aspects...
28 Sep, 2023 Regulation and patentability of NGT plants – what’s next for the UK? By Rebecca Lawrence Dharma Carlin EU Commission Proposal On 5 July 2023, the European Commission proposed a new legislative initiative regarding plants obtained by...
30 Aug, 2023 Bifurcation before the UPC – who filed it first? By Rebecca Lawrence Mary Foord-Weston The Unified Patent Court (UPC) launched on 1 June 2023 and has the power to determine infringement and validity of new Unitary Patents...